questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Amidohydrolases
Amidohydrolases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Amidohydrolases : Questions médicales les plus fréquentes",
"headline": "Amidohydrolases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Amidohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-19",
"dateModified": "2025-03-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Amidohydrolases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hydrolases",
"url": "https://questionsmedicales.fr/mesh/D006867",
"about": {
"@type": "MedicalCondition",
"name": "Hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D006867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "N-acetylmuramoyl-l-alanine amidase",
"alternateName": "N-Acetylmuramoyl-L-alanine Amidase",
"url": "https://questionsmedicales.fr/mesh/D009238",
"about": {
"@type": "MedicalCondition",
"name": "N-acetylmuramoyl-l-alanine amidase",
"code": {
"@type": "MedicalCode",
"code": "D009238",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Allophanate hydrolase",
"alternateName": "Allophanate Hydrolase",
"url": "https://questionsmedicales.fr/mesh/D000492",
"about": {
"@type": "MedicalCondition",
"name": "Allophanate hydrolase",
"code": {
"@type": "MedicalCode",
"code": "D000492",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Formamidase",
"alternateName": "Arylformamidase",
"url": "https://questionsmedicales.fr/mesh/D005558",
"about": {
"@type": "MedicalCondition",
"name": "Formamidase",
"code": {
"@type": "MedicalCode",
"code": "D005558",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Asparaginase",
"alternateName": "Asparaginase",
"url": "https://questionsmedicales.fr/mesh/D001215",
"about": {
"@type": "MedicalCondition",
"name": "Asparaginase",
"code": {
"@type": "MedicalCode",
"code": "D001215",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.116"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase",
"alternateName": "Aspartylglucosylaminase",
"url": "https://questionsmedicales.fr/mesh/D001227",
"about": {
"@type": "MedicalCondition",
"name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase",
"code": {
"@type": "MedicalCode",
"code": "D001227",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "bêta-Lactamases",
"alternateName": "beta-Lactamases",
"url": "https://questionsmedicales.fr/mesh/D001618",
"about": {
"@type": "MedicalCondition",
"name": "bêta-Lactamases",
"code": {
"@type": "MedicalCode",
"code": "D001618",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.180"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cephalosporinase",
"alternateName": "Cephalosporinase",
"url": "https://questionsmedicales.fr/mesh/D002510",
"about": {
"@type": "MedicalCondition",
"name": "Cephalosporinase",
"code": {
"@type": "MedicalCode",
"code": "D002510",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.180.229"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Penicillinase",
"alternateName": "Penicillinase",
"url": "https://questionsmedicales.fr/mesh/D010405",
"about": {
"@type": "MedicalCondition",
"name": "Penicillinase",
"code": {
"@type": "MedicalCode",
"code": "D010405",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.180.697"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Biotinidase",
"alternateName": "Biotinidase",
"url": "https://questionsmedicales.fr/mesh/D043523",
"about": {
"@type": "MedicalCondition",
"name": "Biotinidase",
"code": {
"@type": "MedicalCode",
"code": "D043523",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ceramidases",
"alternateName": "Ceramidases",
"url": "https://questionsmedicales.fr/mesh/D055572",
"about": {
"@type": "MedicalCondition",
"name": "Ceramidases",
"code": {
"@type": "MedicalCode",
"code": "D055572",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acid Ceramidase",
"alternateName": "Acid Ceramidase",
"url": "https://questionsmedicales.fr/mesh/D055573",
"about": {
"@type": "MedicalCondition",
"name": "Acid Ceramidase",
"code": {
"@type": "MedicalCode",
"code": "D055573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.250.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Alkaline Ceramidase",
"alternateName": "Alkaline Ceramidase",
"url": "https://questionsmedicales.fr/mesh/D055574",
"about": {
"@type": "MedicalCondition",
"name": "Alkaline Ceramidase",
"code": {
"@type": "MedicalCode",
"code": "D055574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.250.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neutral Ceramidase",
"alternateName": "Neutral Ceramidase",
"url": "https://questionsmedicales.fr/mesh/D055576",
"about": {
"@type": "MedicalCondition",
"name": "Neutral Ceramidase",
"code": {
"@type": "MedicalCode",
"code": "D055576",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.250.650"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Dihydro-orotase",
"alternateName": "Dihydroorotase",
"url": "https://questionsmedicales.fr/mesh/D004080",
"about": {
"@type": "MedicalCondition",
"name": "Dihydro-orotase",
"code": {
"@type": "MedicalCode",
"code": "D004080",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutaminase",
"alternateName": "Glutaminase",
"url": "https://questionsmedicales.fr/mesh/D005972",
"about": {
"@type": "MedicalCondition",
"name": "Glutaminase",
"code": {
"@type": "MedicalCode",
"code": "D005972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.483"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Histone deacetylases",
"alternateName": "Histone Deacetylases",
"url": "https://questionsmedicales.fr/mesh/D006655",
"about": {
"@type": "MedicalCondition",
"name": "Histone deacetylases",
"code": {
"@type": "MedicalCode",
"code": "D006655",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.520"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Group III Histone Deacetylases",
"alternateName": "Group III Histone Deacetylases",
"url": "https://questionsmedicales.fr/mesh/D056545",
"about": {
"@type": "MedicalCondition",
"name": "Group III Histone Deacetylases",
"code": {
"@type": "MedicalCode",
"code": "D056545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.520.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Histone deacetylase 6",
"alternateName": "Histone Deacetylase 6",
"url": "https://questionsmedicales.fr/mesh/D000073864",
"about": {
"@type": "MedicalCondition",
"name": "Histone deacetylase 6",
"code": {
"@type": "MedicalCode",
"code": "D000073864",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.520.350"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nicotinamidase",
"alternateName": "Nicotinamidase",
"url": "https://questionsmedicales.fr/mesh/D009535",
"about": {
"@type": "MedicalCondition",
"name": "Nicotinamidase",
"code": {
"@type": "MedicalCode",
"code": "D009535",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.610"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Penicillin amidase",
"alternateName": "Penicillin Amidase",
"url": "https://questionsmedicales.fr/mesh/D010399",
"about": {
"@type": "MedicalCondition",
"name": "Penicillin amidase",
"code": {
"@type": "MedicalCode",
"code": "D010399",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.690"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase",
"alternateName": "Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase",
"url": "https://questionsmedicales.fr/mesh/D043524",
"about": {
"@type": "MedicalCondition",
"name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase",
"code": {
"@type": "MedicalCode",
"code": "D043524",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.725"
}
}
},
{
"@type": "MedicalWebPage",
"name": "5-Oxoprolinase(ATP-hydrolysing)",
"alternateName": "Pyroglutamate Hydrolase",
"url": "https://questionsmedicales.fr/mesh/D011752",
"about": {
"@type": "MedicalCondition",
"name": "5-Oxoprolinase(ATP-hydrolysing)",
"code": {
"@type": "MedicalCode",
"code": "D011752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Urease",
"alternateName": "Urease",
"url": "https://questionsmedicales.fr/mesh/D014510",
"about": {
"@type": "MedicalCondition",
"name": "Urease",
"code": {
"@type": "MedicalCode",
"code": "D014510",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.902"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Amidohydrolases",
"alternateName": "Amidohydrolases",
"code": {
"@type": "MedicalCode",
"code": "D000581",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rolandas Meškys",
"url": "https://questionsmedicales.fr/author/Rolandas%20Me%C5%A1kys",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania."
}
},
{
"@type": "Person",
"name": "Yumei Hu",
"url": "https://questionsmedicales.fr/author/Yumei%20Hu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China."
}
},
{
"@type": "Person",
"name": "Longhai Dai",
"url": "https://questionsmedicales.fr/author/Longhai%20Dai",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Sinofn (Tianjin) Pharmaceutical Technology Co., Ltd, Tianjin 300308, PR China."
}
},
{
"@type": "Person",
"name": "Du Niu",
"url": "https://questionsmedicales.fr/author/Du%20Niu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China."
}
},
{
"@type": "Person",
"name": "Zhenzhen Xie",
"url": "https://questionsmedicales.fr/author/Zhenzhen%20Xie",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "An increase in a long noncoding RNA ANRIL in peripheral plasma is an indicator of stable angina.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37852142",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clinsp.2023.100289"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of long noncoding RNA GAS5 gene polymorphism with progression of diabetic kidney disease.",
"datePublished": "2024-08-13",
"url": "https://questionsmedicales.fr/article/39239549",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7150/ijms.99545"
}
},
{
"@type": "ScholarlyArticle",
"name": "Whole transcriptome analysis of long noncoding RNA in beryllium sulfate-treated 16HBE cells.",
"datePublished": "2022-06-06",
"url": "https://questionsmedicales.fr/article/35679967",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.taap.2022.116097"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel long noncoding RNA AC092718.4 as a prognostic biomarker and promotes lung adenocarcinoma progression.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36490353",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18632/aging.204426"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Long Noncoding RNA Derived from lncRNA-mRNA Networks Modulates Seed Vigor.",
"datePublished": "2022-08-22",
"url": "https://questionsmedicales.fr/article/36012737",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23169472"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Amidohydrolases",
"item": "https://questionsmedicales.fr/mesh/D000581"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Amidohydrolases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Amidohydrolases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Amidohydrolases",
"description": "Comment diagnostiquer une déficience en amidohydrolases ?\nQuels tests sanguins sont utilisés pour évaluer les amidohydrolases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème d'amidohydrolases ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Amidohydrolases",
"description": "Quels sont les symptômes d'une déficience en amidohydrolases ?\nLes troubles métaboliques sont-ils liés aux amidohydrolases ?\nY a-t-il des signes cutanés associés aux troubles enzymatiques ?\nLes symptômes varient-ils selon le type d'amidohydrolase ?\nLes symptômes sont-ils immédiats ou progressifs ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Amidohydrolases",
"description": "Peut-on prévenir les troubles liés aux amidohydrolases ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nUne alimentation équilibrée peut-elle prévenir ces troubles ?\nLes vaccinations ont-elles un rôle dans la prévention ?\nL'éducation sur les maladies héréditaires est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Amidohydrolases",
"description": "Quels traitements existent pour les déficiences en amidohydrolases ?\nLes médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?\nLa thérapie génique est-elle une option pour ces troubles ?\nLes changements alimentaires peuvent-ils améliorer les symptômes ?\nY a-t-il des traitements naturels pour les troubles d'amidohydrolases ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Amidohydrolases",
"description": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?\nLes troubles d'amidohydrolases peuvent-ils affecter la croissance ?\nY a-t-il des risques de maladies auto-immunes ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Amidohydrolases",
"description": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?\nL'âge influence-t-il le risque de troubles enzymatiques ?\nLes maladies métaboliques augmentent-elles le risque ?\nLe mode de vie peut-il influencer le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en amidohydrolases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés pour évaluer les amidohydrolases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages enzymatiques dans le sérum peuvent indiquer l'activité des amidohydrolases."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des biopsies peuvent être nécessaires pour évaluer l'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème d'amidohydrolases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles digestifs ou métaboliques peuvent signaler une anomalie enzymatique."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en amidohydrolases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des ballonnements et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils liés aux amidohydrolases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité enzymatique anormale peut entraîner divers troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés aux troubles enzymatiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent survenir en raison de déséquilibres métaboliques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'amidohydrolase ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils immédiats ou progressifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être progressifs, se développant avec le temps en fonction de la déficience."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux amidohydrolases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque de déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Une alimentation équilibrée peut-elle prévenir ces troubles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé enzymatique, mais ne garantit pas la prévention."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne sont pas directement liées à la prévention des troubles enzymatiques."
}
},
{
"@type": "Question",
"name": "L'éducation sur les maladies héréditaires est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation peut aider les familles à comprendre et à gérer les risques associés."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les déficiences en amidohydrolases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent moduler l'activité enzymatique, mais leur efficacité varie."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour ces troubles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires peuvent-ils améliorer les symptômes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation adaptée peut aider à gérer les symptômes liés aux déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour les troubles d'amidohydrolases ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines approches naturelles peuvent aider, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications digestives, métaboliques et neurologiques peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les troubles d'amidohydrolases peuvent-ils affecter la croissance ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déficiences enzymatiques peuvent entraîner des retards de croissance chez les enfants."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies auto-immunes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les troubles enzymatiques et les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications potentielles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies génétiques et des régimes alimentaires déséquilibrés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de troubles enzymatiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles enzymatiques se manifestent plus fréquemment à des âges spécifiques."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies métaboliques peuvent prédisposer à des déficiences en amidohydrolases."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il influencer le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie malsain, incluant une mauvaise alimentation, peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes liés aux amidohydrolases."
}
}
]
}
]
}
Stable angina develops during physical activity or stress, and it is typically an aspect of Coronary Heart Disease (CHD) that can lead to arrhythmia, heart failure and even sudden death. ANRIL, an Ant...
The authors enrolled 62 patients with myocardial infarction and 59 with stable angina before primary percutaneous coronary intervention, as well as 48 healthy volunteers. Their peripheral blood was co...
The data showed that ANRIL is a better diagnostic indicator than cardiac troponin I in patients with stable angina and that the levels of ANRIL are higher in patients with stable angina than those wit...
The levels of ANRIL in peripheral plasma could be used as a good biomarker for stable angina....
Diabetic kidney disease (DKD) is a common microvascular complication of diabetes, whose complex etiology involves a genetic component....
Beryllium and its compounds can cause pulmonary interstitial fibrosis through mechanisms that are not yet clear. Long non-coding RNA (lncRNA) is implicated in various diseases. The molecular toxicity ...
Long noncoding RNAs (lncRNAs) reportedly play critical roles in the pathogenesis of various cancers, including lung adenocarcinoma (LUAD). However, the expression level, clinical significance, and pot...
The discovery of long noncoding RNAs (lncRNAs) has filled a great gap in our understanding of posttranscriptional gene regulation in a variety of biological processes related to plant stress responses...
The pleiotropic function of long noncoding RNAs is well recognized, but their direct role in governing metabolic homeostasis is less understood. Here, we describe a human adipocyte-specific lncRNA, AD...
Accumulating evidence has highlighted that lncRNA ABHD11-AS1 plays an essential role in tumorigenesis and is expected to become a new predictive biomarker and ideal target for cancer therapy, whereas ...
Eight databases were comprehensively screened for relevant articles on January 1, 2024. The significance of ABHD11-AS1 in malignancies was determined by odds ratios (ORs) or hazard ratios (HRs) with c...
Fourteen clinical studies comprising eight kinds of malignancies and 1215 malignancy cases were enrolled into this meta-analysis. The pooled results showed that increased ABHD11-AS1 expression was rem...
Current evidence supports the association of elevated ABHD11-AS1 expression with poor prognosis. Thereby, ABHD11-AS1 may be considered as a promising biomarker to screen cancer and predict malignancy ...
Cartilage homeostasis is essential for chondrocytes to maintain proper phenotype and metabolism. Because adult articular cartilage is avascular, chondrocytes must survive in low oxygen conditions, and...
Stress-induced myocardial perfusion defects found in dipyridamole-thallium-201 single-photon emission computed tomography imaging may indicate vascular perfusion abnormalities and risk of obstructive ...
Optimized strategies for risk classification are essential to tailor therapy for patients with biologically distinctive disease. Risk classification in pediatric acute myeloid leukemia (pAML) relies o...
To identify lncRNA transcripts associated with outcomes, we evaluated the annotated lncRNA landscape by transcript sequencing of 1,298 pediatric and 96 adult AML specimens. Upregulated lncRNAs identif...
Training set cases with positive lncScores had 5-year EFS and overall survival rates of 26.7% and 42.7%, respectively, compared with 56.9% and 76.3% with negative lncScores (hazard ratio, 2.48 and 3.1...
Inclusion of the lncScore enhances predictive power of traditional cytogenetic and mutation-defined stratification in pAML with potential, as a single assay, to replace these complex stratification sc...